CLINICAL TRIALS PROFILE FOR MECLOMEN
✉ Email this page to a colleague
All Clinical Trials for MECLOMEN
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02930005 ↗ | Pentosan Polysulfate Sodium and Meclofenamic Acid as Treatments in Patients With Psychotic Disorders | Completed | The University of Texas Health Science Center, Houston | Phase 2 | 2015-08-07 | This study evaluates the feasibility of administering meclofenamic acid or pentosan polysulfate sodium as an adjunctive treatment to patients diagnosed with a psychotic disorder. Half of participants will receive meclofenamic acid, while the other half will receive polysulfate sodium. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for MECLOMEN
Condition Name
Clinical Trial Locations for MECLOMEN
Trials by Country
Clinical Trial Progress for MECLOMEN
Clinical Trial Phase
Clinical Trial Sponsors for MECLOMEN
Sponsor Name